Abiraterone acetate plus prednisone versus placebo plus prednisone in chemotherapy-naive men with metastatic castration-resistant prostate cancer (COU-AA-302): final overall survival analysis of a randomised, double-blind, placebo-controlled phase 3 study

Charles J Ryan, Matthew R Smith, Karim Fizazi, Fred Saad, Peter F A Mulders, Cora N Sternberg, Kurt Miller, Christopher J Logothetis, Neal D Shore, Eric J Small, Joan Carles, Thomas W Flaig, Mary-Ellen Taplin, Celestia S Higano, Paul de Souza, Johann S de Bono, Thomas W Griffin, Peter De Porre, Margaret K Yu, Youn C Park, Jinhui Li, Thian Kheoh, Vahid Naini, Arturo Molina, Dana E Rathkopf

Journal: The Lancet Oncology

Publisher: Elsevier BV

Citations are the number of DOI-registered works in Crossref that cite this paper; references are how many works it cites. Full text is on the publisher site via the DOI link.